Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2009 and based in Paris, France, Kurma Partners is a venture capital firm managing approximately €890 million in assets. The firm focuses on funding healthcare and biotechnology companies across various stages, from pre-seed to growth equity. They have financed over 72 companies since inception.
Kurma Partners primarily invests in the healthcare and biotechnology sectors, targeting early-stage companies. Their strategy includes collaboration with leading European research centers to develop medical solutions. Investment stages range from pre-seed to Series C and growth equity, with a strong emphasis on innovation.
Notable companies in Kurma Partners' portfolio include Adcytherix, Altamira Therapeutics, Alveus Therapeutics, Amolyt Pharma, Cardiologs, DNA Script, Ganymed Robotics, ImCheck, Pharvaris, and Xeltis.
Email your pitch deck to contact@kurmapartners.com for consideration.
Yes, Kurma Partners often leads investment rounds, particularly in early-stage healthcare and biotech companies.
Kurma Partners is open to follow-on investments, especially for companies that demonstrate significant growth potential and align with their focus areas.
Kurma Partners manages approximately €890 million in assets across their funds.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.